Rethinking R&D

The growing public health threat of antimicrobial resistance could kill 10 million people a year by 2050. And some of the blame lies in the failure of today’s profit-driven research and development system to produce effective and affordable antibiotics, argue researchers Ishu Kataria and Madhur Sachan.
 
AMR’s rise has been significant in countries such as India, which suffers from poor public health infrastructure, high burden of disease and rampant unregulated antibiotic sales. To curb future AMR crises, Kataria and Sachan say, antibiotic innovation requires a more holistic and sustainable R&D model, driven by needs, not profit, with affordability as a guiding principle.

Source: The Huffington Post

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top